[1]
G. Kapoor, N. Singh, Role of apoptotic markers in paediatric acute lymphoblastic leukaemia,
Indian J Med Res,
2018,
147, 225-227. [
Crossref], [
Google Scholar], [
Publisher]
[2] S. Abdelmabood, A.E. Fouda, F. Boujettif, A. Mansour, Treatment outcomes of children with acute lymphoblastic leukemia in a middle-income developing country: high mortalities, early relapses, and poor survival,
Jornal de Pediatria,
2020,
96, 108–116. [
Crossref], [
Google Scholar], [
Publisher]
[3] A. Cahyadi, E. Poespitaningtyas, D.K. Arumsari, M. C. S. Larasati, M. R. Andarsini, I. D.G. Ugrasena, Region variation of hematological mlignancies and
solid tumors in children in East Java,
Asian J Heal Res,
2023,
2, 27−33. [
Crossref], [
Google Scholar], [
Publisher]
[4] T. Liu, E. Raetz, P.J. Moos, S.L. Perkins, C.S. Bruggers, F. Smith, W.L. Carroll, Diversity of the apoptotic response to chemotherapy in childhood leukemia,
Leukemia,
2002,
16, 223-232. [
Crossref], [
Google Scholar], [
Publisher]
[5] A. Kakaje, M.M. Alhalabi, A. Ghareeb, B. Karam, B. Mansour, B. Zahra, O. Hamdan, Rates and trends of childhood acute lymphoblastic leukaemia: an epidemiology study,
Sci Rep,
2020,
10, 6756. [
Crossref], [
Google Scholar], [
Publisher]
[6] V.R. Lakshmidevi, D. Reeja, A.R. Rajan, B. Vinod, Advanced spectrum of imidazole derivatives in therapeutics: A review,
Journal of Chemical Reviews,
2023,
5, 241-262. [
Crossref], [
Pdf], [
Publisher]
[7] R. Kareem, N. Bulut, O. Kaygili, Hydroxyapatite biomaterials: A comprehensive review of their properties, structures, medical applications, and fabrication methods,
Journal of Chemical Reviews,
2023,
6, 1-26. [
Crossref], [
Google Scholar], [
Publisher]
[8] M. Hassan, H. Watari, A. AbuAlmaaty, Y. Ohba, N. Sakuragi, Apoptosis and molecular targeting therapy in cancer,
Biomed Res Int.,
2014,
2014, 150845. [
Crossref], [
Google Scholar], [
Publisher]
[9] A. Muslihatin, M.R. Andarsini, A. Cahyadi, R.V. Prasetyo, I.D.G. Ugrasena, M.C.S. Larasanti, Renal function features in pediatric acute lymphoblastic leukemia during high-dose methotrexate chemotherapy,
Bali Medical Journal,
2022,
11, 1587–1590. [
Crossref], [
Google Scholar], [
Publisher]
[10] H.M. Al-Aamri, H.R. Irving, C. Bradley, T. Meehan-Andrews, Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment,
BMC Cancer,
2021,
21, 438. [
Google Scholar], [
Publisher]
[12] S. Trino, L. De Luca, I. Laurenzana, A. Caivano, L. Del Vecchio, G. Martinelli, P. Musto, P53-MDM2 pathway: evidences for a new targeted therapeutic approach in B-acute lymphoblastic leukemia,
Front Pharmacol,
2016,
7, 491. [
Crossref], [
Google Scholar], [
Publisher]
[13] C. Xiong, P. Li, Q. Luo, C.W. Phan, Q. Li, X. Jin, W. Huang, Induction of apoptosis in heLa cells by a novel peptide from fruiting bodies of morchella importuna via the mitochondrial apoptotic pathway,
Evid Based Complement Alternat Med,
2021,
2021, 5563367. [
Crossref], [
Google Scholar], [
Publisher]
[14] P. Li, L. Zhou, T. Zhao, X. Liu, P. Zhang, Y. Liu, X. Zheng, Q. Li, Caspase-9: structure, mechanisms, and clinical application,
Oncotarget,
2017,
8, 23996-24008. [
Crossref], [
Google Scholar], [
Publisher]
[15] P.M. Edathara, M. Gorre, S. Kagita, A. Cingeetham, S. Annamaneni, R. Digumarti, V. Satti, Influence of caspase-9 polymorphisms on the development of Chronic Myeloid Leukemia- A case-control study,
Gene,
2019,
721S, 100002. [
Crossref], [
Google Scholar], [
Publisher]
[16] N. Novia, N. Rosdiana, S. Supriatmo, Serum ferritin level in pediatric patients with acute lymphoblastic leukemia (ALL) in the early stage of diagnosis and remission phase,
Bali Medical Journal,
2022,
11, 1598–1602. [
Crossref], [
Google Scholar], [
Publisher]
[17] S. Chiaretti, G. Zini, R. Bassan. Diagnosis and Subclassification of Acute Lymphoblastic Leukemia,
Mediterr J Hematol Infect Dis,
2014,
6, 1–12. [
Crossref], [
Google Scholar], [
Publisher]
[18] N. Andria, A.G. Moelyo, M. Reza, Blood glucose level during induction phase chemotherapy in childhood acute lymphoblastic leukemia,
Paediatrica Indonesiana, 2020,
60, 192-197. [
Crossref], [
Google Scholar], [
Publisher]
[19] L. Holmes Jr, J. Hossain, M. Desvignes-Kendrick, F. Opara, Sex variability in pediatric leukemia survival: large cohort evidence,
ISRN Oncol,
2012,
2012, 439070. [
Crossref], [
Google Scholar], [
Publisher]
[20] H. Butt, A. Khalid, M. Yaqoob, Polymorphismm of BCL2 gene in acute lymphoblastic leukemia pastients in Pakistan and screening of phytochemicals to overcome its expression,
Bio Med (Aligarh),
2017,
10, 1000424. [
Crossref], [
Google Scholar], [
Publisher]
[21] E.J. Salim, K. Ariawati, I.W. Gustawan, I.G.A.T. Windiani, E. Gunawijaya, I.N.B. Hartawan, Diagnostic accuracy of bone marrow morphology to determine remission in acute lymphoblastic leukemia children: the role of minimal residual disease,
Bali Medical Journal,
2020,
9, 366–370. [
Crossref], [
Google Scholar], [
Publisher]
[22] J.C. Jaime-Pérez, M.A. Pinzón-Uresti, R.A. Jiménez-Castillo, J.E. Colunga-Pedraza, Ó. González-Llano, D. Gómez-Almaguer, Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor,
Hematology,
2018,
23, 1-9. [
Crossref], [
Google Scholar], [
Publisher]
[23] K.J. Endrawati, N.N Mahartini, S. Herawati, A T-acute lymphoblastic leukemia in children with CD 117 expression: a case report,
Bali Medical Journal,
2019,
8, 577–582. [
Crossref], [
Google Scholar], [
Publisher]
[24] Z. Madadi, S. Akbari-Birgani, P.D. Monfared, S. Mohammadi, The non-apoptotic role of caspase-9 promotes differentiation in leukemic cells,
Biochim Biophys Acta Mol Cell Res,
2019,
1866, 118524. [
Crossref], [
Google Scholar], [
Publisher]
[25] R.T. Clarke, A. Van den Bruel, C. Bankhead, C.D. Mitchell, B. Phillips, M.J. Thompson, Clinical presentation of childhood leukaemia: a systematic review and meta-analysis,
Arch Dis Child,
2016,
101, 894-901. [
Crossref], [
Google Scholar], [
Publisher]
[26] M.J. Hossain, L. Xie, S.M. McCahan, Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis,
J Cancer Epidemiol,
2014,
2014, 865979. [
Crossref], [
Google Scholar], [
Publisher]
[27] K. Kustiah, Y. Hernaningsih, Y, Acute Lymphoblastic Leukemia (B-ALL) with co-expression of CD33 and CD13,
Bali Medical Journal, 2023,
12. [
Crossref], [
Google Scholar], [
Publisher]
[28] R. Kanagal-Shamanna, P. Jain, K. Takahashi, N.J .Short, G. Tang, G.C. Issa, F. Ravandi, G. Garcia-Manero, C.C. Yin, R. Luthra, K.P. Patel, J.D. Khoury, G. Montalban-Bravo, K. Sasaki, T.M. Kadia, G. Borthakur, M. Konopleva, N. Jain, R. Garris, S. Pierce, W. Wierda, Z. Estrov, J. Cortes, S. O’Brien, H.M. Kantarijan, E. Jabbour, TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens,
Cancer,
2017,
123, 3717-3724. [
Crossref], [
Google Scholar], [
Publisher]
[29] K.R. Schultz, D.J. Pullen, H.N. Sather, J.J. Shuster, M. Devidas, M.J. Borowitz, A.J. Carroll, N.A. Heerema, J.E. Rubnitz, M.L. Loh, E.A. Raetz, N.J. Winick, S.P. Hunger, W.L. Carroll, P.S. Gaynon, B.M. Camitta, Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG),
Blood,
2007, 109, 926-35. [
Crossref], [
Google Scholar], [
Publisher]
[30] M.B. Uddin, M. Hoque, M. Ali, A. Islam, R. Miah, Abandonment and outcome of induction chemotherapy in childhood acute lymphoblastic leukemia,
Research In Cancer and Tumor,
2021,
9, 8-14. [
Crossref], [
Google Scholar], [
Publisher]
[31] W.K. Abdullah, F.A. Maha, Caspase 9 gene expression and caspase 9 proten in chronic myeloid leukemia in IRAQ,
Iraqi Journal of Agricultural Sciences,
2022,
53, 994-1002. [
Google Scholar], [
Publisher]
[32] J. Dörrie, H. Gerauer, Y. Wachter, S.J Zunino, Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells,
Cancer Res,
2001, 61, 4731-4739. [
Google Scholar], [
Publisher]
[33] K. Janssen, S. Pohlmann, R.U. Janicke, K. Schulze-Osthoff, U. Fischer, Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment,
Blood, 2007,
110, 3662–72. [
Crossref], [
Google Scholar], [
Publisher]
[34] M.R. Nasution, P.C. Tampubolon, I.S. Nasution, Absolute neutrophil count as predictor hematopoietic recovery in acute lymphoblastic leukemia in remission induction phase chemotherapy,
Bali Medical Journal,
2022,
11, 471–475. [
Google Scholar], [
Publisher]
[35] I. Herr, E. Ucur, K. Herzer, S. Okouoyo, R. Ridder, P.H. Krammer, M.V.K. Doeberitz, K.M. Debatin, Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas,
Cancer Res,
2003, 63, 3112-3120. [
Google Scholar], [
Publisher]
[36] W. Xu, S. Jiang, Y. Xu, B. Chen, Y. Li, F. Zong, W. Zhao, J. Wu, A meta-analysis of caspase 9 polymorphisms in promoter and exon sequence on cancer Susceptibility,
PLoS One,
2012,
7, 37443. [
Crossref], [
Google Scholar], [
Publisher]
[37] S. Sharifi, J. Barar, M.S. Hejazi, N. Samadi, Doxorubicin changes Bax/Bcl-xl ratio, caspase-8 and caspase-9 in breast cancer cells,
Adv Pharm Bull,
2015,
5, 351-359. [
Crossref], [
Google Scholar], [
Publisher]
[38] S.M. Warli, D.R.L. Ringoringo, B. Sihombing, G.P. Siregar, F.F. Prapiska, The role of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in determining the prognosis of patients with testicular cancer,
Bali Medical Journal,
2022,
11, 373–376. [
Crossref], [
Google Scholar], [
Publisher]
[39] S. McComb, P.K. Chan, A. Guinot, H. Hartmannsdottir, S. Jenni, M.P. Dobay, J.P. Bourquin, B.C. Bornhauser, Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7,
Sci Adv,
2019,
5, 9433.[
Crossref], [
Google Scholar], [
Publisher]